A structural model of the extracellular domain of the oncogenic EGFR variant Xmrk

Zebrafish

Volumn 3, Issue 3, 2006, Pages 359-369

  Meierjohann, Svenja ^a   Mueller, Thomas ^a   Schartl, Manfred ^a   Buehner, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

XIPHOPHORUS; XIPHOPHORUS HELLERII; XIPHOPHORUS MACULATUS;

EID: 33750028210     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2006.3.359     Document Type: Article

References (30)

1. Winnemoeller D, Wellbrock C, Schartl M. Activating mutations in the extracellular domain of the melanoma inducing receptor Xmrk are tumorigenic in vivo. Int J Cancer 2005;117:723-729.
2. Geissinger E, Weisser C, Fischer P, Schartl M, Wellbrock C. Autocrine stimulation by osteopontin contributes to antiapoptotic signaling of melanocytes in dermal collagen. Cancer Res 2002;62:4820-4828.
3. Morcinek JC, Weisser C, Geissinger E, Schartl M, Wellbrock C. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signaling mediated by the oncogenic Xmrk kinase. Oncogene 2002;21:1668-1678.
4. Wellbrock C, Weisser C, Geissinger E, Troppmair J, Schartl M. Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling. J Biol Chem 2002;277:6443-6454.
5. Wellbrock C, Fischer P, Schartl M. Receptor tyrosine kinase Xmrk mediates proliferation in Xiphophorus melanoma cells. Int J Cancer 1998;76:437-442.
6. Kazianis S, Gutbrod H, Nairn RS, McEntire BB, Della Coletta L, Walter RB, et al. Localization of a CDKN2 gene in linkage group V of Xiphophorus fish defines it as a candidate for the DIFF tumor suppressor. Genes Chromosomes Cancer 1998;22:210-220.
7. Anders F. Contributions of the Gordon-Kosswig melanoma system to the present concept of neoplasia. Pigment Cell Res 1991;4:7-29.
8. Vielkind J, Vielkind U. Melanoma formation in fish of the genus Xiphophorus: a genetically-based disorder in the determination and differentiation of a specific pigment cell. Can J Genet Cytol 1982;24:133-149.
9. Wittbrodt J, Adam D, Malitschek B, Maueler W, Raulf F, Telling A, et al. Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature 1989;341:415-421.
10. Meierjohann S, Schartl M, Volff JN. Genetic, biochemical and evolutionary facets of Xmrk-induced melanoma formation in the fish Xiphophorus. Comp Biochem Physiol C Toxicol Pharmacol 2004;138:281-289.
11. Volff JN, Korting C, Froschauer A, Zhou Q, Wilde B, Schultheis C, et al. The Xmrk oncogene can escape nonfunctionalization in a highly unstable subtelomeric region of the genome of the fish Xiphophorus. Genomics 2003;82:470-479.
12. Halaban R. The regulation of normal melanocyte proliferation. Pigment Cell Res 2000;13:4-14.
13. Dome B, Raso E, Dobos J, Meszaros L, Varga N, Puskas LG, et al. Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype. Int J Cancer 2005;116:27-35.
14. Natali PG, Nicotra MR, Di Renzo MF, Prat M, Bigotti A, Cavaliere R, et al. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 1993;68:746-750.
15. Yu Y, Merlino G. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model. Cancer Res 2002;62:2951-2956.
16. Purge KA, Kiewlich D, Le P, Vo MN, Faure M, Howlett AR, et al. Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc Natl Acad Sci USA 2001;98:10722-10727.
17. Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 2004;61:2924-2931.
18. Stove C, Stove V, Derycke L, Van Marck V, Mareel M, Bracke M. The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation. J Invest Dermatol 2003;121:802-812.
19. Bardeesy N, Kim M, Xu J, Kim RS, Shen Q, Bosenberg MW, et al. Role of epidermal growth factor receptor signaling in RAS-driven melanoma. Mol Cell Biol 2005;25:4176-4188.
20. Robertson SC, Tynan J, Donoghue DJ. RTK mutations and human syndromes: when good receptors turn bad. Trends Genet 2000;16:265-271.
21. Boerner JL, Danielsen A, Maihle NJ. Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm. Exp Cell Res 2003;284:111-121.
22. Gómez A, Wellbrock C, Gutbrod H, Dimitrijevic N, Schartl M. Ligand-independent dimerization and activation of the oncogenic Xmrk receptor by two mutations in the extracellular domain. J Biol Chem 2001;276:3333-3340.
23. Protein Data Bank, URL: www.rcsb.org. Last accessed July 18, 2005.
24. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim J-H, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002;110:775-787.
25. Ferguson KM, Berger MB, Mendrola JM, Cho H-S, Leahy DJ, Lemmon MA. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 2003;11:507-517.
26. Gómez A, Volff JN, Hornung U, Schartl M, Wellbrock C. Identification of a second egfr gene in Xiphophorus uncovers an expansion of the epidermal growth factor receptor family in fish. Mol Biol Evol 2004;21:266-275.
27. Winkler C, Wittbrodt J, Lammers R, Ullrich A, Schartl M. Ligand-dependent tumor induction in medaka fish embryos by a Xmrk receptor tyrosine kinase transgene. Oncogene 1994;9:1517-1525.
28. Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 2004;13:69-78.
29. Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, et al. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol. 2005;25:671-684.
30. Foster R, Griffith R, Ferrao P, Ashman L. Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase. J Mol Graph Model 2004;23:139-152.